Risk of Nephrolithiasis in Patients with Inflammatory Bowel Disease Receiving Biologic Treatment

Introduction: Inflammatory bowel disease is a chronic inflammatory disorder of the gastrointestinal tract. Biologic drugs target specific molecules in the body’s immune system to control inflammation. Recent studies have suggested a potential link between their use and an increased risk of nephrolit...

Descripción completa

Detalles Bibliográficos
Autores principales: Alameddine, Zakaria, Abi Melhem, Racha, Dimachkie, Reem, Rabah, Hussein, Chehab, Hamed, El Khoury, Michel, Qaqish, Faris, Stefanov, Dimitre, El-Sayegh, Suzanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573832/
https://www.ncbi.nlm.nih.gov/pubmed/37834757
http://dx.doi.org/10.3390/jcm12196114

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10573832/
https://www.ncbi.nlm.nih.gov/pubmed/37834757
http://dx.doi.org/10.3390/jcm12196114

Ejemplares similares